Trulieve Cannabis (STU:T0A) Other Financing: €104 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:T0A Trulieve Cannabis Corp STU:T0A
65 GF Score
Price €7.46
GF Value €5.11
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Trulieve Cannabis Other Financing?

Trulieve Cannabis STU:T0A -1.58% 65 Other Financing is €104 Mil as of Mar. 2026. GuruFocus rates STU:T0A with a GF Score™ of 65/100 and a GF Value™ of €5.11 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Trulieve Cannabis's Other Financing for the three months ended in Mar. 2026 was €-3 Mil.

Trulieve Cannabis's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was €104 Mil.

Trulieve Cannabis Other Financing Historical Data

* Premium members only.

The historical data trend for Trulieve Cannabis's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trulieve Cannabis Other Financing Chart

Trulieve Cannabis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.66 23.59 14.57 -24.15 -14.65

Trulieve Cannabis Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.44 -1.95 -2.35 111.44 -3.35
STU:T0A
65GF Score
Trulieve Cannabis Corp STU:T0A
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Trulieve Cannabis Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €104 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of €104 Mil mean?
Trulieve Cannabis (STU:T0A) has a Other Financing of €104 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Trulieve Cannabis and its competitors.
Is Trulieve Cannabis' Other Financing too high?
Trulieve Cannabis' current Other Financing is €104 Mil. Overall, Trulieve Cannabis has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Trulieve Cannabis' Other Financing compare to HROW and ANIP?
Trulieve Cannabis' Other Financing of €104 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Drug Manufacturers company?
A good Other Financing depends on the Drug Manufacturers industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Trulieve Cannabis and its competitors. Trulieve Cannabis's current Other Financing is €104 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trulieve Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Trulieve Cannabis (STU:T0A) is currently considered Significantly Overvalued. The stock's GF Value™ is €5.11, compared to a current price of €7.46 — trading 46% above its estimated fair value. The current Other Financing is €104 Mil. Trulieve Cannabis' overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Trulieve Cannabis (STU:T0A), the current Other Financing is €104 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Trulieve Cannabis (STU:T0A) Overvalued in 2026?

Based on GuruFocus' analysis, Trulieve Cannabis stock appears to be overvalued. The current stock price of €7.46 is trading 46% above its estimated GF Value™ of €5.11. GuruFocus considers Trulieve Cannabis to be Significantly Overvalued.

Key valuation signals for STU:T0A:

  • Other Financing: €104 Mil
  • GF Value™: €5.11 vs. price of €7.46 (46% above fair value)
  • GF Score™: 65/100 with 6 warning signs

No single metric tells the full story. See the STU:T0A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Trulieve Cannabis Business Description

Other Exchanges TRLV:USATRUL:Canada
Address 3494 Martin Hurst Road, Tallahassee, FL, USA, 32312
Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.
65GF Score

Get the complete analysis for STU:T0A

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.46
Price
€5.11
GF Value